Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01330992 · ClinicalTrials.gov registry record · NA

Human Circadian Sensitivity to Very Short Light Pulses

A NA study, sponsored by Brigham and Women's Hospital.

Completed
Registry status
NA
Development phase
400
Enrollment target

NCT01330992 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 400 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01330992, a NA study, has completed, sponsored by Brigham and Women's Hospital.

COMPLETED
Registry status
NA
Development phase
400 participants
Enrollment target

Study Summary

The mammalian eye serves both visual and non-image-forming functions. New information about the non-image-forming anatomy and physiology of the eye has revealed effects of ocular light stimuli on human circadian rhythms, melatonin suppression, heart rate, pupillary reflexes, cognitive performance, alertness and sleep. The results of the proposed work can be used to make predictions about the effects of light, to make recommendations involving exposure to or avoidance of light, and to design environmental lighting, resulting in improved health and alertness and decreased errors and accidents.

Interventions

  • OTHER Ocular light or darkness exposure

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2009-12
Est. Completion 2011-08
Phase NA

Sponsor

Brigham and Women's Hospital

937 total trials

What the Registry Record Tells You About NCT01330992

The ClinicalTrials.gov registry entry for NCT01330992 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Ocular light or darkness exposure is the first listed.

NCT01330992 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01330992 about?

NCT01330992 is a clinical study titled "Human Circadian Sensitivity to Very Short Light Pulses". The mammalian eye serves both visual and non-image-forming functions. New information about the non-image-forming anatomy and physiology of the eye has revealed effects of ocular light stimuli on human circadian rhythms, melatonin suppression, heart rate, pupillary reflexes, cognitive performance, a...

What is the current status of trial NCT01330992?

This trial is currently completed. It is a NA study. The enrollment target is 400 participants. The study started on 2009-12. Estimated completion is 2011-08.

What interventions are being tested in trial NCT01330992?

The interventions under investigation include: Ocular light or darkness exposure (OTHER).

Who is sponsoring clinical trial NCT01330992?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.